McAleer JP, Kolls JK. Contributions of the intestinal microbiome in lung immunity. Eur J Immunol. 2018;48:39–49.
Durack J, Lynch SV. The gut microbiome: Relationships with disease and opportunities for therapy. J Exp Med. 2019;216:20–40.
Wang HX, Wang YP. Gut Microbiota-brain Axis Chin Med J (Engl). 2016;129:2373–80.
Tripathi A, Debelius J, Brenner DA, et al. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15:397–411.
He Y, Wen Q, Yao F, et al. Gut-lung axis: The microbial contributions and clinical implications. Crit Rev Microbiol. 2017;43:81–95.
Liu P, Wang P, Tian DZ, et al. Study on Traditional Chinese Medicine theory of lung being connected with large intestine. J Tradit Chin Med. 2012;32:482–7.
Wang YJ, Zhou D, Feng Y, Chen G, Li N. T-UCRs with digestive and respiratory diseases. Bioorg Med Chem Lett. 2020;30:16–127306.
Rutten EPA, Lenaerts K, Buurman WA, Wouters EFM. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest. 2014;145:245–52.
Lipowska A, Micic D, Cavallo A, McDonald E. Autoimmune Gastrointestinal Dysmotility Due to Small Cell Lung Cancer. Am J Gastroenterol. 2016;111:S981–S981.
Yazar A, Atis S, Konca K, et al. Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome. Am J Gastroenterol. 2001;96:1511–6.
Wang H, Liu JS, Peng SH, et al. Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases. World J Gastroenterol. 2013;19:6794–804.
Abrosimov VN, Ponomareva IB, Nizov AA, Solodun MV. On respiratory manifestations of gastroesophageal reflux disease. Ter Arkh. 2018;90:131–6.
Bai C, Liu T, Xu J, et al. Effect of High Calorie Diet on Intestinal Flora in LPS-Induced Pneumonia Rats. Sci Rep. 2020;10:1701–1701.
Chen CM, Hu ZG, Liu SB, Tseng H. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert Opin Biol Ther. 2012;12:593–608.
Chen CM. Searching for intellectual turning points: Progressive knowledge domain visualization. Proc Natl Acad Sci USA. 2004;101:5303–10.
Huang XQ, Fan XWW, Ying J, Chen SY. Emerging trends and research foci in gastrointestinal microbiome. J Transl Med. 2019;17:67.
Chen C, Leydesdorff L. Patterns of connections and movements in dual-map overlays: A new method of publication portfolio analysis. J Assoc Inf Sci Technol. 2014;65:334–51.
Chaomei SMBC. CiteSpace II: visualization and knowledge discovery in bibliographic databases. In: AMIA Annual Symposium proceedings. 2005
Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20:159–66.
Budden KF, Gellatly SL, Wood DLA, et al. Emerging pathogenic links between microbiota and the gut–lung axis. Nat Revs Microbiol. 2017;15:55–63.
Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS ONE. 2010;5:1.
Sun TJ, Lu JM, Sheng BP, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut. 2016;65:475–83.
Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS ONE. 2011;6:2-e16384.
Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011;184:957–63.
Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A. 2011;108:5354–9.
Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359:91–7.
Huttenhower C, Gevers D, Knight R, et al. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–14.
Marsland BJ, Trompette A, Gollwitzer ES. The Gut-lung axis in respiratory disease. Ann Am Thorac Soc. 2015;12:S150–6.
Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun. 2005;73:30–8.
Morris A, Beck JM, Schloss PD, et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med. 2013;187:1067–75.
Forsythe P, Inman MD, Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med. 2007;175:561–9.
Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer t cell function. Science. 2012;336:489–93.
Bassis CM, Erb-Downward JR, Dickson RP, et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio. 2015;6:2-e00037.
Wang J, Li FQ, Wei HM, et al. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J Exp Med. 2014;211:2683–2683.
Brown RL, Sequeira RP, Clarke TB. The microbiota protects against respiratory infection via GM-CSF signaling. Nat Commun. 2017;8:1–1512.
Matson V, Fessler J, Bao R, et al. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients. Science. 2018;359:104–8.
Sivan A, Corrales L, Hubert N, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084–9.
Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359:97–103.
Vetizou M, Pitt JM, Daillere R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079–84.
Xia L, Liu Y, Wang Y. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions. Oncologist. 2019;24:S31–41.
Dickson RP, Singer BH, Newstead MW, et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol. 2016;1:10–16113.
Dickson RP, Schultz MJ, van der Poll T, et al. Lung microbiota predict clinical outcomes in critically ill patients. Am J Respir Crit Care Med. 2020;201:555–63.
Dickson RP. The microbiome and critical illness. Lancet Respir Med. 2016;4:59–72.
Ashley SL, Sjoding MW, Popova AP, et al. Lung and gut microbiota are altered by hyperoxia and contribute to oxygen-induced lung injury in mice. Sci Transl Med. 2020;12:556.
Alemao CA, Budden KF, Gomez HM, et al. Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders. Allergy. 2021;76:714–34.
Donovan C, Liu G, Shen S, et al. The role of the microbiome and the NLRP3 inflammasome in the gut and lung. J Leukoc Biol. 2020;108:925–35.
Rufting S, Xenaki D, Malouf M, et al. Short-chain fatty acids increase TNF alpha-induced inflammation in primary human lung mesenchymal cells through the activation of p38 MAPK. Am J Physiol-Lung Cell Molecu Physiol. 2019;316:L157–74.
Bowerman KL, Rehman SF, Vaughan A, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun. 2020;11:1–5886.
Youn YJ, Maureen G, Ozorio DSV, Anujit S, Ian MD. Gut microbiota and immune system interactions. Microorganisms. 2020;8:10–1587.
Mjosberg J, Rao A. Lung inflammation originating in the gut. Science. 2018;359:36–7.
Huang Y, Mao K, Chen X, et al. S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science. 2018;359:114–9.
Chen L-W, Chen P-H, Hsu C-M. Commensal Microflora Contribute to Host Defense Against Escherichia Coli Pneumonia Through Toll-Like Receptors. Shock. 2011;36:67–75.
Yu H, Jianhui W, Fang L, Yuan S. Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections. Front Microbiol. 2020;11:1302.
Isabel H, Baines KJ, Berthan BS, et al. Soluble fibre meal challenge reduces airway inflammation and expression of GPR43 and GPR41 in Asthma. Nutrients. 2017;9:1–57.
Tomoda K, Kubo K, Dairiki K, et al. Whey peptide-based enteral diet attenuated elastase-induced emphysema with increase in short chain fatty acids in mice. BMC Pulm Med. 2015;15:1–7.
Chang TB. Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands. Infect Immunity. 2014;82:4596–606.
Mahooti M, Abdolalipour E, Salehzadeh A, et al. Immunomodulatory and prophylactic effects of Bifidobacterium bifidum probiotic strain on influenza infection in mice. World J Microbiol Biotechnol. 2019;35:6–91.
Abrahamsson TR, Jakobsson HE, Andersson AF, et al. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy. 2014;44:842–50.
Arrieta MC, Stiemsma LT, Dimitriu PA, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7:307.
Alhasan MM, Cait AM, Heimesaat MM, et al. Antibiotic use during pregnancy increases offspring asthma severity in a dose-dependent manner. Allergy. 2020;75:1979–90.
Loewen K, Monchka B, Mahmud SM, Jong G, Azad MB. Prenatal antibiotic exposure and childhood asthma: a population-based study. Eur Respir J. 2018;52:1702070.
Sagar S, Morgan ME, Chen S, et al. Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma. Respir Res. 2014;15:1–46.
Ekbom A, Brandt L, Granath F, Lofdahl CG, Egesten A. Increased risk of both ulcerative colitis and Crohn’s disease in a population suffering from COPD. Lung. 2008;186:167–72.
Roussos A, Koursarakos P, Patsopoulos D, Gerogianni I, Philippou N. Increased prevalence of irritable bowel syndrome in patients with bronchial asthma. Respir Med. 2003;97:75–9.
Vutcovici M, Bitton A, Ernst P, et al. Inflammatory bowel disease and risk of mortality in COPD. Eur Respir J. 2016;47:1357–64.
Burke DG, Fouhy F, Harrison MJ, et al. The altered gut microbiota in adults with cystic fibrosis. BMC Microbiol. 2017;17:1–58.
Hu AG, Lu J, Meng LA, et al. Associations between gut microbial colonization in early life and respiratory outcomes in cystic fibrosis. J Pediatrics. 2015;167:138–47.
Wei-Quan Z, Shu-Kang Z, Jun-Wen L, et al. Alterations of fecal bacterial communities in patients with lung cancer. Am J Transl Res. 2018;10:3171–85.
Qiu M, Huang K, Liu Y, et al. Modulation of intestinal microbiota by glycyrrhizic acid prevents high-fat diet-enhanced pre-metastatic niche formation and metastasis. Mucosal Immunol. 2019;12:945–57.
Gui Q-F, Lu H-F, Zhang C-X, Xu Z-R, Yang Y-H. Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model. Genet Mol Res. 2015;14:5642–51.
Busra A, Belma A. Gut-lung axis and dysbiosis in COVID-19. Turk J Biol. 2020;44:265–72.
Dhar D, Mohanty A. Gut microbiota and Covid-19-possible link and implications. Virus Res. 2020;285:198018.
Udds DA, Maryam M, Muhammed W, et al. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed Pharmacother. 2021;133:110947.
Gabriella DE, Giancarlo C, Massimiliano M, et al. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Front Med. 2020;7:389.